HYPERION DEFI, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
HYPERION DEFI, INC. (HYPD) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $904.44 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2025-04-15
- HYPERION DEFI, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-12-31 was $0.00.
- HYPERION DEFI, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-09-30 was $0.00.
- HYPERION DEFI, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-06-30 was $553.96K.
- HYPERION DEFI, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-03-31 was $350.47K, a 342.62% increase year-over-year.
- HYPERION DEFI, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $904.44K, a 23.75% decline from fiscal 2022.
- HYPERION DEFI, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $1.19M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $553.96K derived: sum of 3 quarters · filed 2025-04-15 | $904.44K 10-K · filed 2025-04-15 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $553.96K derived: sum of 2 quarters · filed 2024-11-12 | $904.44K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $553.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $904.44K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $350.47K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $1.19M 10-K · filed 2024-03-18 | |||
| 2022-03-31 | $79.18K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |